Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.20) by 60 percent. This is a 33.33 percent increase over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $16.64 million which missed the analyst consensus estimate of $19.95 million by 16.59 percent. This is a 9.32 percent decrease over sales of $18.35 million the same period last year.